SHW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sherwin-Williams is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 who does not want to wait for a better entry. The stock is near a pivot point in pre-market, but the chart is still technically weak, the latest options flow is only mildly supportive, analysts are mixed, and insider selling is increasing. While congress buying is a positive and the business remains a high-quality franchise, the current setup does not offer a clean, high-conviction long-term buy at this price. I would not buy aggressively here; holding for a clearer trend or better pullback is the better call.
SHW is trading at 305.75 pre-market, just above the pivot level of 305.413, with resistance at 313.527 and support at 297.299. The MACD histogram is positive at 0.479 but contracting, which suggests momentum is improving only modestly rather than strongly. RSI_6 at 39.598 is neutral-to-weak, showing no clear bullish momentum. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which confirms the broader trend is still under pressure. Near-term pattern analysis suggests a possible small bounce, but the setup does not yet show a durable uptrend.
["Congress trading shows 2 purchase transactions and 0 sales in the last 90 days, a positive sentiment signal.", "Evercore ISI raised its price target to $400 and kept an Outperform rating, showing continued long-term confidence.", "The company remains viewed as a strong market-share gainer in coatings.", "Pre-market price is holding just above pivot support, which keeps a short-term bounce scenario alive."]
["Nippon Paint and Sherwin-Williams' joint acquisition proposal for AkzoNobel was rejected, removing a potential expansion catalyst.", "Insiders are selling, with selling up 277.59% over the last month.", "Several analysts cut targets in late April and early April, reflecting a softer outlook.", "Wells Fargo downgraded the stock to Equal Weight and cited volume pressure, margin pressure, and tougher housing conditions.", "The broader technical trend remains bearish with SMA_200 above SMA_20 and SMA_5."]
No usable latest-quarter financial snapshot was provided due to a data error, so a full quarter-by-quarter review is not available. From the analyst commentary, the most recent quarter appears to have delivered only modest growth, with BofA noting just 4% year-over-year EPS growth and reiterated 2026 EPS guidance. That points to steady but not accelerating fundamental performance.
Analyst sentiment is mixed but leaning cautiously positive. Evercore ISI remained bullish and recently lifted its target to $400, while UBS and Mizuho still have Buy/Outperform-type views with targets in the high $300s. However, Wells Fargo downgraded the stock, and JPMorgan and BofA both trimmed targets, with BofA staying Neutral. The Wall Street pros view is split: supporters like the company’s market-share gains and quality, while skeptics see pressure from housing, raw materials, and limited near-term upside. Overall, analysts are constructive long term but not strongly enthusiastic at the current price.
